MAZE Maze Therapeutics, Inc.

NEUTRAL Impact: 2/10 8-K
Horizon days Filed May 22, 2026 Processed 18d 9h ago SEC 0001193125-26-237199
8-K context-dependent: Items 5.02
Latest settled — T+5d
MAZE ▼ -7.82% at T+5d
NEUTRAL call ✗ call lost -7.82% · α vs SPY -9.03% · entry $26.35 → $24.29
Next anchor: T+20d in 13d
Last close $23.58 (close Jun 8) · -10.51% from $26.35 entry
Entry anchored
May 22, 2026
via day open
T+1d
-1.14%
call -1.14% · α -1.15%
$26.05
settled 15d ago
T+5d
-7.82%
call -7.82% · α -9.03%
$24.29
settled 9d ago
T+20d
call — · α —
in 13d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Maze Therapeutics disclosed the resignation of Amy Bachrodt, Senior Vice President of Finance, effective June 1, 2026. The resignation is not related to any disagreement with the company's operations, policies, or financial reporting. CFO Misbah Tahir will assume the role of principal accounting officer following her departure.

Actionable Insight

This is a routine senior finance departure with no red flags. The CFO absorbing accounting officer duties suggests no immediate disruption. Monitor for any future 8-K filings regarding a permanent replacement or any unexpected financial reporting changes.

Key Facts

  • Amy Bachrodt, SVP of Finance, resigned effective June 1, 2026.
  • Resignation not due to any disagreement with company operations, policies, or financial reporting.
  • CFO Misbah Tahir will be designated principal accounting officer post-departure.
  • No replacement named for the SVP of Finance role.

Financial Impact

No material financial impact disclosed.

Risk Factors

  • Potential temporary gap in finance leadership if CFO is overburdened.
  • No permanent replacement named could signal difficulty in attracting talent.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-237199
Document: 0001193125-26-237199-index-headers.html0001193125-26-237199
Document: 0001193125-26-237199-index.html0001193125-26-237199
Document: 0001193125-26-237199.txt0001193125-26-237199
7 reports for MAZE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MAZE — sortable, filterable
Type Now
Jun 3, 2026
6d ago
Insider Cluster
BEARISH ★ 4/10
$25.40 $24.27▲ +4.45%▲ +1.85%$23.58 (+7.17%)
May 22, 2026
18d ago
8-K
NEUTRAL ★ 2/10
$26.35 $26.05▼ −1.14%▼ −1.15%$23.58 (−10.51%)
May 18, 2026
22d ago
Insider Cluster
NEUTRAL ★ 3/10
$24.46 $25.03▲ +2.33%▲ +1.29%$23.58 (−3.60%)
May 12, 2026
28d ago
8-K
NEUTRAL ★ 4/10
$26.96 $26.96· 0.00%▲ +0.00%$23.58 (−12.54%)
May 12, 2026
28d ago
Press Release
MIXED ★ 5/10
$26.96 $26.96· 0.00%▲ +0.00%$23.58 (−12.54%)
Apr 22, 2026
6w ago
424B5
NEUTRAL ★ 5/10
$26.01 $25.81▼ −0.77%▼ −1.55%$23.58 (−9.34%)
Mar 25, 2026
10w ago
Press Release
BULLISH ★ 8/10
$31.73 $31.71▼ −0.06%▲ +1.71%$23.58 (−25.69%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access